Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: Drug levels in maternal serum, cord blood, breast milk and the infant's serum

Annals of the Rheumatic Diseases

Volumn 68, Issue 11, 2009, Pages 1793-1794

  Murashima, A ^a,b   Watanabe, N ^a,b   Ozawa, N ^a   Saito, H ^a   Yamaguchi, K ^a,b  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b Japan Drug Information Institute in Pregnancy   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; PREDNISOLONE; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; BREAST MILK; CASE REPORT; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MILK LEVEL; FEMALE; HUMAN; INFANT; LACTATION; LETTER; MATERNAL SERUM; PREGNANCY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; UMBILICAL CORD BLOOD; BLOOD; FETOMATERNAL TRANSFUSION; FETUS BLOOD; METABOLISM; NEWBORN; PREGNANCY COMPLICATION;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; FETAL BLOOD; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; LACTATION; MATERNAL-FETAL EXCHANGE; MILK, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 70449706430     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.105924     Document Type: Letter

References (10)

1. Reed SD, Vollan TA, Svec MA. Pregnancy outcomes in women with rheumatoid arthritis in Washington state. Matern Child Health J 2006;10:361-366
2. Wallace DJ. The use of etanercept and other tumor necrosis factor-alpha blockers in infertility: it's time to get serious. J Rheumatol 2003;30:1897-1899
3. Winger EE, Reed JL. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 2008;60:8-16.
4. Treacy G. Using analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNFa monoclonal antibody. Hum Exp Toxicol 2000;19:226-228 (Pubitemid 30428170)
5. Product information. Enbrel. Thousand Oaks, CA: Immunex, 2001.
6. Mahadevan U, Kane S, Sandborn WJ, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 2005;21:733-738 (Pubitemid 40469001)
7. Chambers CD, Tutuncu ZN, Johnson D, et al. Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther 2006;8:215. (Pubitemid 44363221)
8. Cush JJ. Biological drug use: US perspectives on indications and monitoring. Ann Rheum Dis 2005;64(Suppl 4):iv18-23.
9. Korth-Bradley JM, Rubin AS, Hanna RK, et al. The pharmacokinetics of etanercept in healthy volunteers. Ann Pharmacother 2000;34:161-164
10. Ostensen M, Eigenmann GO. Etanercept in breast milk. J Rheumatol 2004;31:1017-1018